Galderma’s breakthrough drug Nemluvio gains rapid FDA approval for severe itch condition
Galderma has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) approving Nemluvio (nemolizumab) for the treatment of prurigo nodularis in adults. ... Read More
Galderma and L’Oréal join forces to advance dermatology
Galderma, renowned for its leadership in dermatology, and L’Oréal, a giant in beauty and skincare, have unveiled a groundbreaking partnership marked by L’Oréal acquiring a ... Read More
SkinBioTherapeutics partners with Umesh Modi Group for Dermatonics launch in AMEA
SkinBioTherapeutics plc (AIM: SBTX), a leading life science company focused on skin health, has announced a strategic partnership with the Umesh Modi Group, a renowned ... Read More
Clinique partners with Icahn School of Medicine to launch skin health center
Clinique, a leading skincare brand, and the Icahn School of Medicine at Mount Sinai have announced a groundbreaking philanthropic partnership to establish the Mount Sinai-Clinique ... Read More
Aarti Drugs launches dermatology product production at new Tarapur facility
Aarti Drugs Limited (NSE: AARTIDRUGS; BSE:524348), a Mumbai-based pharmaceutical powerhouse, has officially announced the start of its dermatology product production at its newly established facility ... Read More
Arcutis Biotherapeutics gets ZORYVE FDA approval for seborrheic dermatitis
Arcutis Biotherapeutics, Inc., a pioneer in immuno-dermatology, has announced the U.S. Food and Drug Administration's (FDA) approval of their new drug application for ZORYVE (roflumilast) ... Read More
Supriya Lifescience collaborates with Kalinga Institute for innovative skin regeneration gel
Supriya Lifescience, a front-runner in speciality active pharmaceutical ingredients (API) and CDMO services in India, has penned an agreement with Kalinga Institute of Technology for ... Read More
FDA approves Novartis’ Cosentyx for hidradenitis suppurativa treatment
Novartis, a global leader in immuno-dermatology and rheumatology, announced the U.S. Food and Drug Administration's approval of Cosentyx (secukinumab) for treating adults with moderate to ... Read More
EMA validates LEO Pharma’s application for delgocitinib cream in chronic hand eczema
LEO Pharma A/S said that the European Medicines Agency (EMA) has validated its marketing authorization application (MAA) for delgocitinib cream. Touted as a groundbreaking topical ... Read More
Eris Lifesciences strikes deal for Dr. Reddy’s cosmetic dermatology brands
Eris Lifesciences has announced the acquisition of nine cosmetic dermatology brands in the Indian market from Dr. Reddy's Laboratories for INR 275 crores in cash. ... Read More